Piracetam (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Piracetam" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

22nih.gov

4^th place

8^th place

17doi.org

2^nd place

5^th place

6worldcat.org

5^th place

10^th place

4web.archive.org

1^st place

2^nd place

3sciencedirect.com

149^th place

140^th place

2google.ca

838^th place

139^th place

2archive.org

6^th place

9^th place

2fda.gov

447^th place

409^th place

1netdoctor.co.uk

9,484^th place

5,391^st place

1acmedsci.ac.uk

low place

1newyorker.com

146^th place

834^th place

1compendium.ch

low place

1watoday.com.au

9,548^th place

low place

1spectrumchemical.com

low place

1wiley.com

222^nd place

163^rd place

1canada.ca

1,712^th place

2,524^th place

1draagle.com

low place

1over.net

low place

2,559^th place

acmedsci.ac.uk

Brain science, addiction and drugs (PDF) (poročilo). Academy of Medical Sciences. Maj 2008. str. 145. ISBN 1-903401-18-6.

archive.org

Koskiniemi, M; Van Vleymen, B; Hakamies, L; Lamusuo, S; Taalas, J (1998). »Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo«. Journal of Neurology, Neurosurgery, and Psychiatry. Zv. 64, št. 3. str. 344–8. doi:10.1136/jnnp.64.3.344. PMC 2169975. PMID 9527146.
Chouinard, G; Annable, L; Ross-Chouinard, A; Olivier, M; Fontaine, F (1983). »Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment«. Psychopharmacology. 81 (2): 100–6. doi:10.1007/BF00429000. PMID 6415738.

canada.ca

Canada, Health. »Guidance Document on the Import Requirements for Health Products under the Food and Drugs Act and its Regulations (GUI-0084) - Canada.ca«. www.canada.ca (v angleščini). Arhivirano iz prvotnega spletišča dne 3. decembra 2017. Pridobljeno 2. decembra 2017.

compendium.ch

Nootropil®. Arzneimittel-Kompendium der Schweiz. 2013-09-12. Retrieved 2013-10-27.

doi.org

Flicker, L; Grimley Evans, G (2001). »Piracetam for dementia or cognitive impairment«. The Cochrane database of systematic reviews. Št. 2. str. CD001011. doi:10.1002/14651858.CD001011. PMID 11405971.
Waegemans, T; Wilsher, CR; Danniau, A; Ferris, SH; Kurz, A; Winblad, B (2002). »Clinical efficacy of piracetam in cognitive impairment: a meta-analysis«. Dementia and geriatric cognitive disorders. Zv. 13, št. 4. str. 217–24. doi:10.1159/000057700. PMID 12006732.
Winblad, B (2005). »Piracetam: a review of pharmacological properties and clinical uses«. CNS Drug Reviews. Zv. 11, št. 2. str. 169–82. doi:10.1111/j.1527-3458.2005.tb00268.x. PMID 16007238.
»Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders«. Drugs. Zv. 70, št. 3. Februar 2010. str. 287–312. doi:10.2165/11319230-000000000-00000. PMID 20166767.
Al Hajeri, Amani; Fedorowicz, Zbys (12. februar 2016). »Piracetam for reducing the incidence of painful sickle cell disease crises«. The Cochrane Database of Systematic Reviews. Zv. 2. str. CD006111. doi:10.1002/14651858.CD006111.pub3. ISSN 1469-493X. PMID 26869149.
Koskiniemi, M; Van Vleymen, B; Hakamies, L; Lamusuo, S; Taalas, J (1998). »Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo«. Journal of Neurology, Neurosurgery, and Psychiatry. Zv. 64, št. 3. str. 344–8. doi:10.1136/jnnp.64.3.344. PMC 2169975. PMID 9527146.
De Reuck, J; Van Vleymen, B (1999). »The clinical safety of high-dose piracetam--its use in the treatment of acute stroke«. Pharmacopsychiatry. Zv. 32 Suppl 1. str. 33–7. doi:10.1055/s-2007-979234. PMID 10338106.
Fedi, M; Reutens, D; Dubeau, F; Andermann, E; D'agostino, D; Andermann, F (2001). »Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy«. Archives of neurology. Zv. 58, št. 5. str. 781–6. doi:10.1001/archneur.58.5.781. PMID 11346373.
Giurgea, C.; Salama, M. (1977). »Nootropic drugs«. Prog Neuropsychopharmacol. Zv. 1, št. 3–4. str. 235–247. doi:10.1016/0364-7722(77)90046-7.
Chouinard, G; Annable, L; Ross-Chouinard, A; Olivier, M; Fontaine, F (1983). »Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment«. Psychopharmacology. 81 (2): 100–6. doi:10.1007/BF00429000. PMID 6415738.
Hakkarainen, H; Hakamies, L (1978). »Piracetam in the treatment of post-concussional syndrome. A double-blind study«. European neurology. Zv. 17, št. 1. str. 50–5. doi:10.1159/000114922. PMID 342247.
Ahmed, Ahmed H.; Oswald, Robert E. (11. marec 2010). »Piracetam Defines a New Binding Site for Allosteric Modulators of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors«. Journal of medicinal chemistry. Zv. 53, št. 5. str. 2197–2203. doi:10.1021/jm901905j. ISSN 0022-2623. PMC 2872987. PMID 20163115.
Gouliaev, Alex Haahr; Senning, Alexander (1. maj 1994). »Piracetam and other structurally related nootropics«. Brain Research Reviews. Zv. 19, št. 2. str. 180–222. doi:10.1016/0165-0173(94)90011-6.
»Maintenance page : Wiley Online Library«. doi:10.1002/ddr.430020505/abstract. {{navedi revijo}}: Sklic magazine potrebuje|magazine= (pomoč)
Müller, W. E.; Eckert, G. P.; Eckert, A. (Marec 1999). »Piracetam: novelty in a unique mode of action«. Pharmacopsychiatry. Zv. 32 Suppl 1. str. 2–9. doi:10.1055/s-2007-979230. ISSN 0176-3679. PMID 10338102.
Grau, M.; Montero, J. L.; Balasch, J. (1. januar 1987). »Effect of piracetam on electrocorticogram and local cerebral glucose utilization in the rat«. General Pharmacology: The Vascular System. Zv. 18, št. 2. str. 205–211. doi:10.1016/0306-3623(87)90252-7.
Nickolson, Victor J.; Wolthuis, Otto L. (15. oktober 1976). »Effect of the acquisition-enhancing drug ptracetam on rat cerebral energy metabolism. Comparison with naftidrofuryl and methamphetamine«. Biochemical Pharmacology. Zv. 25, št. 20. str. 2241–2244. doi:10.1016/0006-2952(76)90004-6.

draagle.com

si.draagle.com

»Draagle -- Vse o zdravilih«. si.draagle.com. Arhivirano iz prvotnega spletišča dne 7. decembra 2017. Pridobljeno 2. decembra 2017.

fda.gov

Inspections, Compliance, Enforcement, and Criminal Investigations

accessdata.fda.gov

»Enforcement Report - Week of 20 March 2013«. Arhivirano iz prvotnega spletišča dne 30. aprila 2016. Pridobljeno 14. novembra 2017.

google.ca

books.google.ca

Li, Jie Jack; Corey, E. J. (2013). Drug Discovery: Practices, Processes, and Perspectives (v angleščini). John Wiley & Sons. str. 276. ISBN 9781118354469.
M.D, Emeritus Profess of Neurology and Head of Epilepsy Research Group Berlin Dieter Schmidt; Shorvon, Emeritus Profess of Neurology and Consultant Neurologist Simon (2016). The End of Epilepsy?: A History of the Modern Era of Epilepsy Research 1860-2010 (v angleščini). Oxford University Press. str. 69. ISBN 9780198725909.

netdoctor.co.uk

»Nootropil«. NetDoctor.co.uk. 8. julij 2004. Arhivirano iz prvotnega spletišča dne 2. januarja 2012. Pridobljeno 21. septembra 2009.

newyorker.com

Talbot, Margaret (27. april 2009). »Brain Gain: The underground world of 'neuroenhancing' drugs«. The New Yorker. Pridobljeno 21. septembra 2009.

nih.gov

pubmed.ncbi.nlm.nih.gov

Flicker, L; Grimley Evans, G (2001). »Piracetam for dementia or cognitive impairment«. The Cochrane database of systematic reviews. Št. 2. str. CD001011. doi:10.1002/14651858.CD001011. PMID 11405971.
Waegemans, T; Wilsher, CR; Danniau, A; Ferris, SH; Kurz, A; Winblad, B (2002). »Clinical efficacy of piracetam in cognitive impairment: a meta-analysis«. Dementia and geriatric cognitive disorders. Zv. 13, št. 4. str. 217–24. doi:10.1159/000057700. PMID 12006732.
Winblad, B (2005). »Piracetam: a review of pharmacological properties and clinical uses«. CNS Drug Reviews. Zv. 11, št. 2. str. 169–82. doi:10.1111/j.1527-3458.2005.tb00268.x. PMID 16007238.
»Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders«. Drugs. Zv. 70, št. 3. Februar 2010. str. 287–312. doi:10.2165/11319230-000000000-00000. PMID 20166767.
Al Hajeri, Amani; Fedorowicz, Zbys (12. februar 2016). »Piracetam for reducing the incidence of painful sickle cell disease crises«. The Cochrane Database of Systematic Reviews. Zv. 2. str. CD006111. doi:10.1002/14651858.CD006111.pub3. ISSN 1469-493X. PMID 26869149.
Koskiniemi, M; Van Vleymen, B; Hakamies, L; Lamusuo, S; Taalas, J (1998). »Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo«. Journal of Neurology, Neurosurgery, and Psychiatry. Zv. 64, št. 3. str. 344–8. doi:10.1136/jnnp.64.3.344. PMC 2169975. PMID 9527146.
De Reuck, J; Van Vleymen, B (1999). »The clinical safety of high-dose piracetam--its use in the treatment of acute stroke«. Pharmacopsychiatry. Zv. 32 Suppl 1. str. 33–7. doi:10.1055/s-2007-979234. PMID 10338106.
Fedi, M; Reutens, D; Dubeau, F; Andermann, E; D'agostino, D; Andermann, F (2001). »Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy«. Archives of neurology. Zv. 58, št. 5. str. 781–6. doi:10.1001/archneur.58.5.781. PMID 11346373.
Chouinard, G; Annable, L; Ross-Chouinard, A; Olivier, M; Fontaine, F (1983). »Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment«. Psychopharmacology. 81 (2): 100–6. doi:10.1007/BF00429000. PMID 6415738.
Hakkarainen, H; Hakamies, L (1978). »Piracetam in the treatment of post-concussional syndrome. A double-blind study«. European neurology. Zv. 17, št. 1. str. 50–5. doi:10.1159/000114922. PMID 342247.
Ahmed, Ahmed H.; Oswald, Robert E. (11. marec 2010). »Piracetam Defines a New Binding Site for Allosteric Modulators of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors«. Journal of medicinal chemistry. Zv. 53, št. 5. str. 2197–2203. doi:10.1021/jm901905j. ISSN 0022-2623. PMC 2872987. PMID 20163115.
Jordaan, B.; Oliver, D. W.; Dormehl, I. C.; Hugo, N. (september 1996). »Cerebral blood flow effects of piracetam, pentifylline, and nicotinic acid in the baboon model compared with the known effect of acetazolamide«. Arzneimittel-Forschung. Zv. 46, št. 9. str. 844–847. ISSN 0004-4172. PMID 8876930.{{navedi revijo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Winnicka, Katarzyna; Tomasiak, Marian; Bielawska, Anna (september 2005). »Piracetam--an old drug with novel properties?«. Acta Poloniae Pharmaceutica. Zv. 62, št. 5. str. 405–409. ISSN 0001-6837. PMID 16459490.{{navedi revijo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Müller, W. E.; Eckert, G. P.; Eckert, A. (Marec 1999). »Piracetam: novelty in a unique mode of action«. Pharmacopsychiatry. Zv. 32 Suppl 1. str. 2–9. doi:10.1055/s-2007-979230. ISSN 0176-3679. PMID 10338102.
Tacconi, M. T.; Wurtman, R. J. (1986). »Piracetam: physiological disposition and mechanism of action«. Advances in Neurology. Zv. 43. str. 675–685. ISSN 0091-3952. PMID 3946121.

ncbi.nlm.nih.gov

Al Hajeri, Amani; Fedorowicz, Zbys (12. februar 2016). »Piracetam for reducing the incidence of painful sickle cell disease crises«. The Cochrane Database of Systematic Reviews. Zv. 2. str. CD006111. doi:10.1002/14651858.CD006111.pub3. ISSN 1469-493X. PMID 26869149.
Koskiniemi, M; Van Vleymen, B; Hakamies, L; Lamusuo, S; Taalas, J (1998). »Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo«. Journal of Neurology, Neurosurgery, and Psychiatry. Zv. 64, št. 3. str. 344–8. doi:10.1136/jnnp.64.3.344. PMC 2169975. PMID 9527146.
Ahmed, Ahmed H.; Oswald, Robert E. (11. marec 2010). »Piracetam Defines a New Binding Site for Allosteric Modulators of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors«. Journal of medicinal chemistry. Zv. 53, št. 5. str. 2197–2203. doi:10.1021/jm901905j. ISSN 0022-2623. PMC 2872987. PMID 20163115.
Jordaan, B.; Oliver, D. W.; Dormehl, I. C.; Hugo, N. (september 1996). »Cerebral blood flow effects of piracetam, pentifylline, and nicotinic acid in the baboon model compared with the known effect of acetazolamide«. Arzneimittel-Forschung. Zv. 46, št. 9. str. 844–847. ISSN 0004-4172. PMID 8876930.{{navedi revijo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Winnicka, Katarzyna; Tomasiak, Marian; Bielawska, Anna (september 2005). »Piracetam--an old drug with novel properties?«. Acta Poloniae Pharmaceutica. Zv. 62, št. 5. str. 405–409. ISSN 0001-6837. PMID 16459490.{{navedi revijo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Müller, W. E.; Eckert, G. P.; Eckert, A. (Marec 1999). »Piracetam: novelty in a unique mode of action«. Pharmacopsychiatry. Zv. 32 Suppl 1. str. 2–9. doi:10.1055/s-2007-979230. ISSN 0176-3679. PMID 10338102.
Tacconi, M. T.; Wurtman, R. J. (1986). »Piracetam: physiological disposition and mechanism of action«. Advances in Neurology. Zv. 43. str. 675–685. ISSN 0091-3952. PMID 3946121.

over.net

med.over.net

»PIRACETAM«. med.over.net. Pridobljeno 2. decembra 2017.

sciencedirect.com

Gouliaev, Alex Haahr; Senning, Alexander (1. maj 1994). »Piracetam and other structurally related nootropics«. Brain Research Reviews. Zv. 19, št. 2. str. 180–222. doi:10.1016/0165-0173(94)90011-6.
Grau, M.; Montero, J. L.; Balasch, J. (1. januar 1987). »Effect of piracetam on electrocorticogram and local cerebral glucose utilization in the rat«. General Pharmacology: The Vascular System. Zv. 18, št. 2. str. 205–211. doi:10.1016/0306-3623(87)90252-7.
Nickolson, Victor J.; Wolthuis, Otto L. (15. oktober 1976). »Effect of the acquisition-enhancing drug ptracetam on rat cerebral energy metabolism. Comparison with naftidrofuryl and methamphetamine«. Biochemical Pharmacology. Zv. 25, št. 20. str. 2241–2244. doi:10.1016/0006-2952(76)90004-6.

spectrumchemical.com

»Piracetam Material Safety Sheet« (PDF). Spectrum.

watoday.com.au

Medew, Julia (1. oktober 2009). »Call for testing on 'smart drugs'«. WA Today (v ameriški angleščini). Pridobljeno 2. decembra 2017.

web.archive.org

»Enforcement Report - Week of 20 March 2013«. Arhivirano iz prvotnega spletišča dne 30. aprila 2016. Pridobljeno 14. novembra 2017.
»Nootropil«. NetDoctor.co.uk. 8. julij 2004. Arhivirano iz prvotnega spletišča dne 2. januarja 2012. Pridobljeno 21. septembra 2009.
Canada, Health. »Guidance Document on the Import Requirements for Health Products under the Food and Drugs Act and its Regulations (GUI-0084) - Canada.ca«. www.canada.ca (v angleščini). Arhivirano iz prvotnega spletišča dne 3. decembra 2017. Pridobljeno 2. decembra 2017.
»Draagle -- Vse o zdravilih«. si.draagle.com. Arhivirano iz prvotnega spletišča dne 7. decembra 2017. Pridobljeno 2. decembra 2017.

wiley.com

onlinelibrary.wiley.com

»Maintenance page : Wiley Online Library«. doi:10.1002/ddr.430020505/abstract. {{navedi revijo}}: Sklic magazine potrebuje|magazine= (pomoč)

worldcat.org

Al Hajeri, Amani; Fedorowicz, Zbys (12. februar 2016). »Piracetam for reducing the incidence of painful sickle cell disease crises«. The Cochrane Database of Systematic Reviews. Zv. 2. str. CD006111. doi:10.1002/14651858.CD006111.pub3. ISSN 1469-493X. PMID 26869149.
Ahmed, Ahmed H.; Oswald, Robert E. (11. marec 2010). »Piracetam Defines a New Binding Site for Allosteric Modulators of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors«. Journal of medicinal chemistry. Zv. 53, št. 5. str. 2197–2203. doi:10.1021/jm901905j. ISSN 0022-2623. PMC 2872987. PMID 20163115.
Jordaan, B.; Oliver, D. W.; Dormehl, I. C.; Hugo, N. (september 1996). »Cerebral blood flow effects of piracetam, pentifylline, and nicotinic acid in the baboon model compared with the known effect of acetazolamide«. Arzneimittel-Forschung. Zv. 46, št. 9. str. 844–847. ISSN 0004-4172. PMID 8876930.{{navedi revijo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Winnicka, Katarzyna; Tomasiak, Marian; Bielawska, Anna (september 2005). »Piracetam--an old drug with novel properties?«. Acta Poloniae Pharmaceutica. Zv. 62, št. 5. str. 405–409. ISSN 0001-6837. PMID 16459490.{{navedi revijo}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Müller, W. E.; Eckert, G. P.; Eckert, A. (Marec 1999). »Piracetam: novelty in a unique mode of action«. Pharmacopsychiatry. Zv. 32 Suppl 1. str. 2–9. doi:10.1055/s-2007-979230. ISSN 0176-3679. PMID 10338102.
Tacconi, M. T.; Wurtman, R. J. (1986). »Piracetam: physiological disposition and mechanism of action«. Advances in Neurology. Zv. 43. str. 675–685. ISSN 0091-3952. PMID 3946121.